Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases.
暂无分享,去创建一个
Norbert Meyer | Hideaki Morita | Reto Crameri | Cezmi A Akdis | Remo Frei | C. Akdis | M. Akdiş | M. Sokolowska | A. Eljaszewicz | R. Frei | R. Ferstl | W. van de Veen | O. Wirz | R. Crameri | L. O’Mahony | T. Eiwegger | Thomas Eiwegger | Claudio Rhyner | Ana Rebane | Ruth Ferstl | Carly Huitema | M. Wawrzyniak | Mübeccel Akdis | Liam O'Mahony | Marija Pezer | N. Meyer | A. Aab | A. Głobińska | C. Rhyner | A. Rebane | Alar Aab | Marcin Wawrzyniak | C. Huitema | Milena Sokolowska | Willem van de Veen | Terufumi Kubo | Kazunari Sugita | Andrzej Eljaszewicz | Kursat Azkur | Mattia Garbani | Anna Globinska | Lena Hess | Zsolt Komlosi | Patricia Konieczna | Nora Kovacs | Judith Olzhausen | Paulina Wawrzyniak | Can Altunbulakli | Rita A Costa | Su Duan | Umut C Kucuksezer | Moira Prati | Arturo Rinaldi | Barbara Stanic | Angela Treis | Kerstin Wanke | Oliver F Wirz | Josefina Sierra Zakzuk | K. Sugita | M. Garbani | B. Stanić | T. Kubo | H. Morita | M. Prati | A. Treis | P. Wawrzyniak | Arturo O. Rinaldi | Z. Komlósi | S. Duan | C. Altunbulakli | K. Azkur | Lena Hess | Patricia Konieczna | Nóra Kovács | J. Olzhausen | K. Wanke | J. Zakzuk | U. Kucuksezer | Marija Pezer | Rita Costa | Norbert Meyer | Anna Głobińska | Alar Aab | Angela Treis | Kerstin Wanke | Su Duan | Ruth Ferstl
[1] C. Dinarello,et al. A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[2] S. Pestka,et al. Cloning, expression and initial characterisation of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10) , 2000, Genes and Immunity.
[3] C. Akdis,et al. Therapeutic manipulation of immune tolerance in allergic disease , 2009, Nature Reviews Drug Discovery.
[4] Donavan T. Cheng,et al. Thymic stromal lymphopoietin receptor blockade reduces allergic inflammation in a cynomolgus monkey model of asthma. , 2013, The Journal of allergy and clinical immunology.
[5] R. Hromas,et al. Cutting Edge: IL-17D, a Novel Member of the IL-17 Family, Stimulates Cytokine Production and Inhibits Hemopoiesis1 , 2002, The Journal of Immunology.
[6] F. Nestle,et al. Faculty Opinions recommendation of Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. , 2010 .
[7] W. Cruikshank,et al. Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells. , 1982, Journal of immunology.
[8] M. Shmulevitz,et al. Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism. , 2008, Blood.
[9] T. Mcclanahan,et al. A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R1 , 2002, The Journal of Immunology.
[10] R. Flavell,et al. Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. , 2009, Current opinion in pharmacology.
[11] F. D. de Sauvage,et al. IL-27 regulates IL-12 responsiveness of naïve CD4+ T cells through Stat1-dependent and -independent mechanisms , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[12] C. Bachert,et al. Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. , 2013, The Journal of allergy and clinical immunology.
[13] D. Proud,et al. Role of IL-17A and neutrophils in fibrosis in experimental hypersensitivity pneumonitis. , 2013, The Journal of allergy and clinical immunology.
[14] M. Torrero,et al. Immunologic characterization of 3 murine regimens of allergen-specific immunotherapy. , 2015, The Journal of allergy and clinical immunology.
[15] F. Annunziato,et al. The 3 major types of innate and adaptive cell-mediated effector immunity. , 2015, The Journal of allergy and clinical immunology.
[16] T. Walz,et al. Latent TGF-β structure and activation , 2011, Nature.
[17] S. Johnston,et al. Tolerogenic signaling by pulmonary CD1c+ dendritic cells induces regulatory T cells in patients with chronic obstructive pulmonary disease by IL-27/IL-10/inducible costimulator ligand. , 2014, The Journal of allergy and clinical immunology.
[18] P. Pierre,et al. Mapping the crossroads of immune activation and cellular stress response pathways , 2013, The EMBO journal.
[19] M. Diamond,et al. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia , 2012, Nature Immunology.
[20] Richard J Martin,et al. Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33. , 2015, The Journal of allergy and clinical immunology.
[21] T. Mcclanahan,et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. , 2002, Immunity.
[22] A. Gurney,et al. Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[23] Y. Teraki,et al. IL-13/IL-22-coproducing T cells, a novel subset, are increased in atopic dermatitis. , 2013, The Journal of allergy and clinical immunology.
[24] Mayte Suárez-Fariñas,et al. RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications. , 2015, The Journal of allergy and clinical immunology.
[25] F. Mennechet,et al. Interferon-λ-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells , 2006 .
[26] A. Caraffa,et al. IL-36 Receptor Antagonist with Special Emphasis on IL-38 , 2013, International journal of immunopathology and pharmacology.
[27] C. Akdis,et al. IL-10-overexpressing B cells regulate innate and adaptive immune responses. , 2015, The Journal of allergy and clinical immunology.
[28] M. Kaplan,et al. TH9 cells are required for tissue mast cell accumulation during allergic inflammation. , 2015, The Journal of allergy and clinical immunology.
[29] C. Akdis,et al. In vivo switch to IL-10–secreting T regulatory cells in high dose allergen exposure , 2008, The Journal of experimental medicine.
[30] C. Akdis,et al. A novel, dual cytokine‐secretion assay for the purification of human Th22 cells that do not co‐produce IL‐17A , 2016, Allergy.
[31] C. Hsieh,et al. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. , 1993, Science.
[32] A. Hershko,et al. T cell-derived microvesicles induce mast cell production of IL-24: relevance to inflammatory skin diseases. , 2014, The Journal of allergy and clinical immunology.
[33] C. Akdis,et al. Regulation of the foxp3 Gene by the Th1 Cytokines: The Role of IL-27-Induced STAT11 , 2009, The Journal of Immunology.
[34] C. Hawrylowicz,et al. Enhanced production of IL-17A in patients with severe asthma is inhibited by 1α,25-dihydroxyvitamin D3 in a glucocorticoid-independent fashion. , 2013, The Journal of allergy and clinical immunology.
[35] Stacie M Jones,et al. Sustained Unresponsiveness to Peanut in Subjects Who Have Completed Peanut Oral Immunotherapy , 2014, Pediatrics.
[36] S. Saglani,et al. T cells in asthma: influences of genetics, environment, and T-cell plasticity. , 2013, The Journal of allergy and clinical immunology.
[37] S. Durham,et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. , 2009, The Journal of clinical investigation.
[38] Gary D Bader,et al. Interleukin-7 co-ordinates proliferation, differentiation and Tcra recombination during thymocyte β-selection , 2015, Nature Immunology.
[39] S. Way,et al. Pathogen-specific Treg cells expand early during mycobacterium tuberculosis infection but are later eliminated in response to Interleukin-12. , 2013, Immunity.
[40] S. Kotenko,et al. Interferon induction and function at the mucosal surface , 2013, Immunological reviews.
[41] M. Wittmann,et al. IL-33 impacts on the skin barrier by downregulating the expression of filaggrin. , 2015, The Journal of allergy and clinical immunology.
[42] H. Hammad,et al. Barrier Epithelial Cells and the Control of Type 2 Immunity. , 2015, Immunity.
[43] W I Wood,et al. Structure and functional expression of a human interleukin-8 receptor. , 1991, Science.
[44] M. Hernandez,et al. IL-1 receptor antagonist reduces endotoxin-induced airway inflammation in healthy volunteers. , 2015, The Journal of allergy and clinical immunology.
[45] Liviu Ciortuz,et al. IL-9 is a key component of memory TH cell peanut-specific responses from children with peanut allergy. , 2014, The Journal of allergy and clinical immunology.
[46] L. Joosten,et al. IL-1 family nomenclature , 2010, Nature Immunology.
[47] M. Cairo,et al. The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromes , 2007, Leukemia & lymphoma.
[48] L. Hunyady,et al. Crosstalk between TGF-β signaling and the microRNA machinery. , 2012, Trends in pharmacological sciences.
[49] Choon-Sik Park,et al. Interleukin-25 and interleukin-13 production by alveolar macrophages in response to particles. , 2005, American journal of respiratory cell and molecular biology.
[50] C. Uyttenhove,et al. T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor , 1988, The Journal of experimental medicine.
[51] D. Metcalfe,et al. Distinct transcriptome profiles differentiate nonsteroidal anti-inflammatory drug-dependent from nonsteroidal anti-inflammatory drug-independent food-induced anaphylaxis. , 2016, The Journal of allergy and clinical immunology.
[52] C. Akdis,et al. Regulation of T cells and cytokines by the interleukin‐10 (IL‐10)‐family cytokines IL‐19, IL‐20, IL‐22, IL‐24 andIL‐26 , 2006, European journal of immunology.
[53] I. Agache,et al. The Complex Type 2 Endotype in Allergy and Asthma: From Laboratory to Bedside , 2015, Current Allergy and Asthma Reports.
[54] R. Xavier,et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. , 2008, The Journal of clinical investigation.
[55] J. Whisstock,et al. IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction , 2015, Nature Immunology.
[56] S. Sharma,et al. Evidence for an intracellular precursor for human B-cell growth factor. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[57] R. Akhurst. The paradoxical TGF-β vasculopathies , 2012, Nature Genetics.
[58] M. Croft,et al. Rhinovirus infection interferes with induction of tolerance to aeroantigens through OX40 ligand, thymic stromal lymphopoietin, and IL-33. , 2016, The Journal of allergy and clinical immunology.
[59] B. Wan,et al. Recombinant human interleukin-11 (IL-11) is a protective factor in severe sepsis with thrombocytopenia: A case-control study. , 2015, Cytokine.
[60] Yuan Zhang,et al. Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.
[61] J. Kolls,et al. Directing traffic: IL‐17 and IL‐22 coordinate pulmonary immune defense , 2014, Immunological reviews.
[62] Ruchong Chen,et al. Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia. , 2016, The Journal of allergy and clinical immunology.
[63] Scott R. Presnell,et al. IL-28, IL-29 and their class II cytokine receptor IL-28R , 2002, Nature Immunology.
[64] V. Kuchroo,et al. IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39 , 2013, Nature Immunology.
[65] D. Schwartz,et al. A mouse model links asthma susceptibility to prenatal exposure to diesel exhaust. , 2014, The Journal of allergy and clinical immunology.
[66] D. Danilenko,et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17–producing T cells , 2006, Nature Immunology.
[67] Manuel A. R. Ferreira,et al. Allergen-induced IL-6 trans-signaling activates γδ T cells to promote type 2 and type 17 airway inflammation. , 2015, The Journal of allergy and clinical immunology.
[68] P. Schendel,et al. The cloning and biological characterization of recombinant human interleukin 11. , 1992, International journal of cell cloning.
[69] C. Akdis,et al. Differentiation and functional analysis of human T(H)17 cells. , 2009, The Journal of allergy and clinical immunology.
[70] Barbara Rehermann,et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus , 2013, Nature Genetics.
[71] N. Al-Jameil,et al. Thyroid dysfunction: an autoimmune aspect. , 2015, International journal of clinical and experimental medicine.
[72] C. Akdis,et al. Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs. , 2014, The Journal of clinical investigation.
[73] C. Akdis,et al. TH17 cells in the big picture of immunology. , 2007, The Journal of allergy and clinical immunology.
[74] J. Neefjes,et al. Human B cells promote T-cell plasticity to optimize antibody response by inducing coexpression of T(H)1/T(FH) signatures. , 2015, The Journal of allergy and clinical immunology.
[75] Borislav D. Dimitrov,et al. Innate and adaptive T cells in asthmatic patients: Relationship to severity and disease mechanisms , 2015, The Journal of allergy and clinical immunology.
[76] Kian Fan Chung,et al. Targeting the interleukin pathway in the treatment of asthma , 2015, The Lancet.
[77] J. Cowell,et al. Development of autoimmunity in IL-14alpha-transgenic mice. , 2006, Journal of Immunology.
[78] R. Bissonnette,et al. Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis. , 2015, The Journal of allergy and clinical immunology.
[79] M. Pellegrino,et al. The Epithelial Cell-Derived Atopic Dermatitis Cytokine TSLP Activates Neurons to Induce Itch , 2013, Cell.
[80] C. Akdis,et al. IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. , 2013, The Journal of allergy and clinical immunology.
[81] S. Kotenko,et al. Interleukin 24 (MDA-7/MOB-5) Signals through Two Heterodimeric Receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2* , 2002, The Journal of Biological Chemistry.
[82] T. Illig,et al. Identification of novel immune phenotypes for allergic and nonallergic childhood asthma. , 2015, The Journal of allergy and clinical immunology.
[83] K. Boyd,et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function , 2007, Nature.
[84] F. Chisari,et al. Lambda Interferon Inhibits Hepatitis B and C Virus Replication , 2005, Journal of Virology.
[85] R. Flavell,et al. TH2, allergy and group 2 innate lymphoid cells , 2013, Nature Immunology.
[86] Ho‐Youn Kim,et al. Expression of IL-17 homologs and their receptors in the synovial cells of rheumatoid arthritis patients. , 2005, Molecules and cells.
[87] H. Hammad,et al. The immunology of asthma , 2014, Nature Immunology.
[88] G. Mincione,et al. The antitumor potential of Interleukin-27 in prostate cancer , 2013, Oncotarget.
[89] G. Nilsson,et al. Molecular targets on mast cells and basophils for novel therapies. , 2014, The Journal of allergy and clinical immunology.
[90] M. Gold,et al. Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures. , 2014, The Journal of allergy and clinical immunology.
[91] A. Reder,et al. Aberrant Type I Interferon Regulation in Autoimmunity: Opposite Directions in MS and SLE, Shaped by Evolution and Body Ecology , 2013, Front. Immunol..
[92] M. Suárez-Fariñas,et al. Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population. , 2015, The Journal of allergy and clinical immunology.
[93] Z. Su,et al. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. , 1995, Oncogene.
[94] C. Akdis,et al. Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. , 2011, The Journal of allergy and clinical immunology.
[95] A. Fitzpatrick,et al. Characterization of a high TNF-α phenotype in children with moderate-to-severe asthma. , 2015, The Journal of allergy and clinical immunology.
[96] R L Kassel,et al. An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[97] L. Hancox,et al. Inflammatory IL-15 is required for optimal memory T cell responses. , 2015, The Journal of clinical investigation.
[98] J. Baty,et al. Randomized trial to evaluate azithromycin's effects on serum and upper airway IL-8 levels and recurrent wheezing in infants with respiratory syncytial virus bronchiolitis. , 2015, The Journal of allergy and clinical immunology.
[99] C. Mackay,et al. T follicular helper (TFH) cells in normal and dysregulated immune responses. , 2008, Annual review of immunology.
[100] S. Ikemizu,et al. IL-2 and IL-15 signaling complexes: different but the same , 2012, Nature Immunology.
[101] H. Fickenscher,et al. Induction of a Novel Cellular Homolog of Interleukin-10, AK155, by Transformation of T Lymphocytes with Herpesvirus Saimiri , 2000, Journal of Virology.
[102] J. Shelhamer,et al. Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human Macrophages , 2015, The Journal of Immunology.
[103] K. McCoy,et al. IL-2 is a critical regulator of group 2 innate lymphoid cell function during pulmonary inflammation. , 2015, The Journal of allergy and clinical immunology.
[104] H. Kita,et al. Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation , 2015, Current opinion in allergy and clinical immunology.
[105] D. Conklin,et al. Interleukin 20 Discovery, Receptor Identification, and Role in Epidermal Function , 2001, Cell.
[106] C. Ziegler,et al. Thymic stromal lymphopoietin-mediated extramedullary hematopoiesis promotes allergic inflammation. , 2013, Immunity.
[107] C. Dinarello,et al. Human leukocytic pyrogen: purification and development of a radioimmunoassay. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[108] Marc K. Halushka,et al. Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome , 2006, Science.
[109] D. Meyers,et al. Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine. , 2014, The Journal of allergy and clinical immunology.
[110] W. Paul,et al. Identification of a T cell-derived b cell growth factor distinct from interleukin 2 , 1982, The Journal of experimental medicine.
[111] B. Hartmann,et al. Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation. , 2013, The Journal of allergy and clinical immunology.
[112] E. Solary,et al. Editorial: CSF1R, CSF‐1, and IL‐34, a “ménage à trois” conserved across vertebrates , 2010, Journal of leukocyte biology.
[113] T. Hirano,et al. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[114] R. Bataille,et al. Molecular cloning of two isoforms of a receptor for the human hematopoietic cytokine interleukin-11. , 1995, Blood.
[115] D. Postma,et al. Association of IL33-IL-1 receptor-like 1 (IL1RL1) pathway polymorphisms with wheezing phenotypes and asthma in childhood. , 2014, The Journal of allergy and clinical immunology.
[116] C. Akdis,et al. Inhibition of angiogenesis by IL-32: possible role in asthma. , 2012, The Journal of allergy and clinical immunology.
[117] P. Pfeffer,et al. Distinct endotypes of steroid-resistant asthma characterized by IL-17Ahigh and IFN-γhigh immunophenotypes: Potential benefits of calcitriol , 2015, The Journal of allergy and clinical immunology.
[118] S. Szefler,et al. New and future strategies to improve asthma control in children. , 2015, The Journal of allergy and clinical immunology.
[119] J. Vilo,et al. Mechanisms of IFN-γ-induced apoptosis of human skin keratinocytes in patients with atopic dermatitis. , 2012, The Journal of allergy and clinical immunology.
[120] C. Akdis,et al. Increased activation-induced cell death of high IFN-gamma-producing T(H)1 cells as a mechanism of T(H)2 predominance in atopic diseases. , 2008, The Journal of allergy and clinical immunology.
[121] M. Lebwohl,et al. Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing. , 2015, The Journal of allergy and clinical immunology.
[122] K. Schroder,et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases , 2015, Nature Medicine.
[123] K. Nadeau,et al. The future of biologics: applications for food allergy. , 2015, The Journal of allergy and clinical immunology.
[124] P. Valdez,et al. Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis , 2007, Nature.
[125] C. Akdis,et al. TNF-like weak inducer of apoptosis (TWEAK) and TNF-α cooperate in the induction of keratinocyte apoptosis. , 2011, The Journal of allergy and clinical immunology.
[126] C. Akdis,et al. IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. , 2010, The Journal of allergy and clinical immunology.
[127] V. Fung,et al. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. , 1994, Science.
[128] R. D. Hatton,et al. Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.
[129] C. Akdis,et al. Advances in allergen immunotherapy: Aiming for complete tolerance to allergens , 2015, Science Translational Medicine.
[130] S. Kunkel,et al. Chemokines provide the sustained inflammatory bridge between innate and acquired immunity. , 2005, Cytokine & growth factor reviews.
[131] C. Akdis,et al. Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. , 2014, The Journal of allergy and clinical immunology.
[132] C. Akdis,et al. CpG-DNA enhances the tight junction integrity of the bronchial epithelial cell barrier. , 2015, The Journal of allergy and clinical immunology.
[133] J. Renauld,et al. The T-cell Lymphokine Interleukin-26 Targets Epithelial Cells through the Interleukin-20 Receptor 1 and Interleukin-10 Receptor 2 Chains* , 2004, Journal of Biological Chemistry.
[134] Gary D Bader,et al. IL-7 coordinates proliferation, differentiation and Tcra recombination during thymocyte -selection , 2015 .
[135] G. Trinchieri,et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes , 1989, Journal of Experimental Medicine.
[136] Erik Meulmeester,et al. The dynamic roles of TGF‐β in cancer , 2011, The Journal of pathology.
[137] G. Dranoff,et al. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites , 1998, Nature.
[138] P. Gregersen,et al. Structural biology of shared cytokine receptors. , 2009, Annual review of immunology.
[139] Á. Cruz,et al. Coassociations between IL10 polymorphisms, IL-10 production, helminth infection, and asthma/wheeze in an urban tropical population in Brazil. , 2013, The Journal of allergy and clinical immunology.
[140] M. Contoli,et al. Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma. , 2012, The Journal of allergy and clinical immunology.
[141] C. Uyttenhove,et al. Distinct subunit pairing criteria within the heterodimeric IL-12 cytokine family. , 2012, Molecular immunology.
[142] S. Watowich,et al. TH17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26 , 2015, Nature Immunology.
[143] F. Mennechet,et al. Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells. , 2006, Blood.
[144] R. Kelley,et al. IL‐17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL‐17F, and implications for receptor binding , 2001, The EMBO journal.
[145] C. Dinarello,et al. IL-32, a novel cytokine with a possible role in disease , 2006, Annals of the rheumatic diseases.
[146] S. Rutz,et al. The IL-20 subfamily of cytokines — from host defence to tissue homeostasis , 2014, Nature Reviews Immunology.
[147] S. Johnston,et al. Increased nuclear suppressor of cytokine signaling 1 in asthmatic bronchial epithelium suppresses rhinovirus induction of innate interferons , 2015, The Journal of allergy and clinical immunology.
[148] Y. Belkaid,et al. Signaling via the IL-20 receptor inhibits cutaneous production of IL-1β and IL-17A to promote infection with methicillin-resistant Staphylococcus aureus , 2013, Nature Immunology.
[149] L. Wakefield,et al. Beyond TGFβ: roles of other TGFβ superfamily members in cancer , 2013, Nature Reviews Cancer.
[150] Christoph Wilhelm,et al. Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9–producing subset , 2008, Nature Immunology.
[151] M. T. Brewer,et al. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist , 1990, Nature.
[152] C. Leclerc,et al. Dectin-1 activation unlocks IL12A expression and reveals the TH1 potency of neonatal dendritic cells. , 2015, The Journal of allergy and clinical immunology.
[153] M. Fujimoto,et al. B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells. , 2013, The Journal of allergy and clinical immunology.
[154] C. Akdis,et al. Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-β , 2014, Genes and Immunity.
[155] C. Gabay,et al. The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases. , 2015, Cytokine.
[156] E. Coccia,et al. Viral infection and Toll‐like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte‐derived dendritic cells , 2004, European journal of immunology.
[157] M. Leach,et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. , 2001, Immunity.
[158] C. Pignata,et al. High-content cytometry and transcriptomic biomarker profiling of human B-cell activation. , 2014, The Journal of allergy and clinical immunology.
[159] P. Foster,et al. Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity. , 2003, The Journal of allergy and clinical immunology.
[160] C. Akdis,et al. In utero priming by worms protects against respiratory allergies. , 2014, The Journal of allergy and clinical immunology.
[161] Richard A Flavell,et al. Autocrine transforming growth factor-β1 promotes in vivo Th17 cell differentiation. , 2011, Immunity.
[162] D. Broide,et al. Group 2 innate lymphocytes (ILC2) are enriched in active eosinophilic esophagitis. , 2015, The Journal of allergy and clinical immunology.
[163] Haitao Guo,et al. Inflammasomes: mechanism of action, role in disease, and therapeutics , 2015, Nature Medicine.
[164] K. Christopher Garcia,et al. Molecular and Structural Basis of Cytokine Receptor Pleiotropy in the Interleukin-4/13 System , 2008, Cell.
[165] J. Richmond,et al. Regulation of Cellular Processes by Interleukin‐16 in Homeostasis and Cancer , 2014, Journal of cellular physiology.
[166] Nicolás I Torres,et al. IL‐27 stimulates human NK‐cell effector functions and primes NK cells for IL‐18 responsiveness , 2015, European journal of immunology.
[167] S. Georas,et al. Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation. , 2014, The Journal of allergy and clinical immunology.
[168] R. Derynck,et al. Differentiation plasticity regulated by TGF-β family proteins in development and disease , 2007, Nature Cell Biology.
[169] S. Wenzel,et al. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care. , 2015, The Journal of allergy and clinical immunology.
[170] T. Litman,et al. Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection. , 2015, The Journal of allergy and clinical immunology.
[171] N. Frangogiannis,et al. TGF-β signaling in fibrosis , 2011, Growth factors.
[172] R. Derynck,et al. Differentiation plasticity regulated by TGF-|[beta]| family proteins in development and disease , 2007 .
[173] Philippe A. Robert,et al. Assessment of mTOR-Dependent Translational Regulation of Interferon Stimulated Genes , 2015, PloS one.
[174] P. Barnes. Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes. , 2015, The Journal of allergy and clinical immunology.
[175] Hyun-Woo Shin,et al. IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis. , 2015, The Journal of allergy and clinical immunology.
[176] Kathleen M. Smith,et al. Development, cytokine profile and function of human interleukin 17–producing helper T cells , 2007, Nature Immunology.
[177] T. Beaty,et al. Targeted deep sequencing identifies rare loss-of-function variants in IFNGR1 for risk of atopic dermatitis complicated by eczema herpeticum. , 2015, The Journal of allergy and clinical immunology.
[178] D. Broide,et al. Long-term assessment of esophageal remodeling in patients with pediatric eosinophilic esophagitis treated with topical corticosteroids. , 2016, The Journal of allergy and clinical immunology.
[179] W. Paul,et al. Cytokines of the γc family control CD4+ T cell differentiation and function , 2012, Nature Immunology.
[180] L. Boulet,et al. Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. , 2014, The New England journal of medicine.
[181] A. Ray,et al. Patients with cystic fibrosis have inducible IL-17+IL-22+ memory cells in lung draining lymph nodes. , 2013, The Journal of allergy and clinical immunology.
[182] S. Durham,et al. Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation. , 2013, The Journal of allergy and clinical immunology.
[183] C. Akdis,et al. T-cell regulation during viral and nonviral asthma exacerbations. , 2015, The Journal of allergy and clinical immunology.
[184] Steven G. Smith,et al. Thymic stromal lymphopoietin activation of basophils in patients with allergic asthma is IL-3 dependent. , 2015, The Journal of allergy and clinical immunology.
[185] J. Renauld,et al. Interferon-λ and interleukin-22 cooperate for the induction of interferon-stimulated genes and control of rotavirus infection , 2015, Nature Immunology.
[186] C. Akdis,et al. Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-γ and IL-4. , 2012, The Journal of allergy and clinical immunology.
[187] H. Hammad,et al. Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells , 2015, Science.
[188] K. Yasukawa,et al. Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. , 1992, Journal of immunology.
[189] D. Broide,et al. TGF-β1-induced phospholamban expression alters esophageal smooth muscle cell contraction in patients with eosinophilic esophagitis. , 2014, The Journal of allergy and clinical immunology.
[190] Guoqing Ying,et al. Functions of thymic stromal lymphopoietin in non-allergic diseases. , 2015, Cellular immunology.
[191] N. Bannert,et al. Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[192] H. Okamura,et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. , 1995, Nature.
[193] D. Barber,et al. Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation. , 2014, The Journal of allergy and clinical immunology.
[194] A. Patócs. TGF-[beta] signaling and the microRNA machinery , 2013 .
[195] S. Holgate,et al. The innate antiviral response upregulates IL-13 receptor α2 in bronchial fibroblasts. , 2013, The Journal of allergy and clinical immunology.
[196] M. Akdiş. Healthy immune response to allergens: T regulatory cells and more. , 2006, Current opinion in immunology.
[197] R. Flavell,et al. IL-9 Regulates Allergen-Specific Th1 Responses in Allergic Contact Dermatitis , 2014, The Journal of investigative dermatology.
[198] E. Kieff,et al. Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[199] C. Akdis,et al. An Interleukin-33-Mast Cell-Interleukin-2 Axis Suppresses Papain-Induced Allergic Inflammation by Promoting Regulatory T Cell Numbers. , 2015, Immunity.
[200] Nicolas Serafini,et al. Transcriptional regulation of innate lymphoid cell fate , 2015, Nature Reviews Immunology.
[201] Scott R. Presnell,et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice , 2004, Nature Immunology.
[202] A. Bush,et al. Type 2 innate lymphoid cells in induced sputum from children with severe asthma. , 2016, The Journal of allergy and clinical immunology.
[203] C. Garlanda,et al. The interleukin-1 family: back to the future. , 2013, Immunity.
[204] S. Wenzel,et al. IL-27 and type 2 immunity in asthmatic patients: association with severity, CXCL9, and signal transducer and activator of transcription signaling. , 2015, The Journal of allergy and clinical immunology.
[205] D. Largaespada,et al. Cloning of the Murine Thymic Stromal Lymphopoietin (Tslp) Receptor , 2000, The Journal of experimental medicine.
[206] D. Artis,et al. Basophils and allergic inflammation. , 2013, The Journal of allergy and clinical immunology.
[207] T. Buhl,et al. A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1. , 2014, The Journal of allergy and clinical immunology.
[208] P. Bosco,et al. Dysfunction of TGF-β1 signaling in Alzheimer’s disease: perspectives for neuroprotection , 2011, Cell and Tissue Research.
[209] Gerard C. L. Wong,et al. Liquid-crystalline ordering of antimicrobial peptide-DNA complexes controls TLR9 activation. , 2015, Nature materials.
[210] J Fernando Bazan,et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.
[211] D. Artis,et al. Welcome to the neighborhood: epithelial cell‐derived cytokines license innate and adaptive immune responses at mucosal sites , 2008, Immunological reviews.
[212] S. Durham,et al. IL-22 suppresses IFN-γ-mediated lung inflammation in asthmatic patients. , 2013, The Journal of allergy and clinical immunology.
[213] G. Sledge,et al. Cutting Edge: IL-17F, a Novel Cytokine Selectively Expressed in Activated T Cells and Monocytes, Regulates Angiogenesis and Endothelial Cell Cytokine Production1 , 2001, The Journal of Immunology.
[214] K. Hartmann,et al. Serum IL-31 levels are increased in a subset of patients with mastocytosis and correlate with disease severity in adult patients. , 2013, The Journal of allergy and clinical immunology.
[215] R. Ramesh,et al. Phosphorylation of interleukin (IL)-24 is required for mediating its anti-cancer activity , 2015, Oncotarget.
[216] C. Akdis,et al. TH17 and TH22 cells: a confusion of antimicrobial response with tissue inflammation versus protection. , 2012, The Journal of allergy and clinical immunology.
[217] D. Nicolae,et al. A genome-wide survey of CD4(+) lymphocyte regulatory genetic variants identifies novel asthma genes. , 2014, The Journal of allergy and clinical immunology.
[218] J. Cowell,et al. Development of Autoimmunity in IL-14α-Transgenic Mice1 , 2006, The Journal of Immunology.
[219] R. Gallo,et al. Selective in vitro growth of T lymphocytes from normal human bone marrows. , 1976, Science.
[220] Taeg S. Kim,et al. Viral infection of the lung: Host response and sequelae , 2013, Journal of Allergy and Clinical Immunology.
[221] M. Edwards,et al. The Airway Epithelium: Soldier in the Fight against Respiratory Viruses , 2011, Clinical Microbiology Reviews.
[222] D. DeMeo,et al. Polymorphisms in IL13, total IgE, eosinophilia, and asthma exacerbations in childhood. , 2007, The Journal of allergy and clinical immunology.